SANYO CHEMICAL INDUSTRIES (4471) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The cumulative results for Q3 reflect lower revenue but higher profit, with improved profitability being the key focus. Revenue was ¥966.0B (-13.1% YoY), Operating Income was ¥75.6B (+10.0%), Ordinary Income was ¥93.9B (+9.4%), and Net Income was ¥134.3B (+220.1%). The primary reason for the revenue decline was sluggish demand in the Lifestyle and Health Industry-Related segment. Meanwhile, improved profitability in the Petroleum and Transportation Equipment and Information, Electrical and Electronic Industries segments lifted Operating Income. The significant increase in Net Income was largely attributable to income taxes and other taxes resulting in a tax benefit of ¥54.8B; this should be evaluated separately from the Company’s underlying operating performance.

Factors Affecting Performance

【Revenue】Revenue was ¥966.0B, down 13.1% YoY. The Lifestyle and Health Industry-Related segment declined sharply to ¥129.8B (-50.0% YoY), while the Environment and Housing Equipment Industry-Related segment and others fell to ¥99.7B (-11.9%), and the Plastics and Textile Industry-Related segment declined to ¥196.4B (-3.9%). In contrast, the Information, Electrical and Electronic Industry-Related segment was the only segment to achieve revenue growth, increasing to ¥171.1B (+7.7%), while the Petroleum and Transportation Equipment Industry-Related segment remained nearly flat at ¥369.1B (-1.7%).

【Profit and Loss】Operating Income was ¥75.6B (+10.0% YoY), and the Operating Margin improved to 7.8% from 6.2% in the same period last year. The primary factor was the increase in segment profit in the Petroleum and Transportation Equipment segment to ¥43.8B (+41.5%), raising its margin to 11.9%. The Information, Electrical and Electronic segment also maintained the highest level of profitability company-wide, with profit of ¥26.2B (+25.7%) and a margin of 15.3%. On the other hand, the Lifestyle and Health Industry-Related segment fell into an Operating Loss of ¥1.4B, while the Environment and Housing Equipment Industry-Related segment and others posted a loss of ¥0.4B. Ordinary Income was ¥93.9B (+9.4%), supported by non-operating income of ¥21.5B, including dividend income of ¥12.4B and foreign exchange gains of ¥6.7B. Although the Company recorded extraordinary losses of ¥14.7B, including ¥9.9B in losses on disposal of fixed assets, income taxes and other taxes resulted in a tax benefit of ¥54.8B, driving Net Income sharply higher to ¥134.3B (+220.1%). Overall, the Company achieved higher profit despite lower revenue.

Segment Analysis

The Petroleum and Transportation Equipment Industry-Related segment was the largest earnings contributor, with Revenue of ¥369.1B (38.2% of total) and Operating Income of ¥43.8B (51.0% of total segment profit). Although revenue declined YoY, its margin improved from 8.4% to 11.9%. The Information, Electrical and Electronic Industry-Related segment generated Revenue of ¥171.1B (17.7% of total) and had the highest profitability company-wide, with a margin of 15.3%, continuing its trend of higher revenue and profit. The Plastics and Textile Industry-Related segment recorded Revenue of ¥196.4B and a margin of 9.0%, down from 11.0% in the previous year. The Lifestyle and Health Industry-Related segment’s Revenue was halved to ¥129.8B from ¥259.4B in the previous year, and it fell into an Operating Loss of ¥1.4B. Business structural reform expenses, which amounted to ¥20.6B in the previous year, declined to ¥2.3B in the current period, reducing the cost burden. The Environment and Housing Equipment Industry-Related segment and others recorded Revenue of ¥99.7B and an Operating Loss of ¥0.4B. Corporate expenses (adjustments) increased to ¥10.2B from ¥8.1B in the previous year, offsetting part of the improvement in segment profit.

Key Financial Indicators

【Profitability】The Operating Margin improved to 7.8% from 6.2% in the same period last year, while the Ordinary Income Margin was 9.7% and the Net Income Margin was 13.9%. The high Net Income Margin was strongly affected by the tax benefit, and it is appropriate to evaluate the Company’s underlying operating performance based on the Operating Margin.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥150.6B, representing approximately 1.18x the ¥128.1B in Net Income attributable to owners of the parent, indicating strong cash backing for earnings.【Investment Efficiency】ROE was 8.6%. Net assets were ¥1,554.8B against total assets of ¥1,932.1B, indicating that asset efficiency is not high; however, it should be noted that normalized earnings power excluding the tax benefit would be somewhat lower.【Financial Soundness】The Equity Ratio was extremely high at 80.5%. Interest-bearing debt was minimal relative to cash and deposits of ¥310.2B, indicating a conservative and stable financial foundation.

Cash Flow Analysis

Operating Cash Flow (OCF) was ¥150.6B, up 59.5% YoY, and was approximately 1.18x the ¥128.1B in Net Income attributable to owners of the parent, indicating strong cash backing for earnings. In terms of working capital, an increase in trade receivables was a negative factor of ¥21.0B, but this was offset by a ¥37.6B increase in trade payables. The Company secured sufficient cash even after deducting ¥15.6B in income taxes paid. Investing Cash Flow was an outflow of ¥46.4B, primarily reflecting ¥48.8B in capital expenditures. As a result, Free Cash Flow was positive at ¥104.2B. Financing Cash Flow was an outflow of ¥45.4B, mainly due to dividend payments of ¥37.5B. Cash and deposits had accumulated to ¥310.2B, indicating that the Company is allocating cash generated from operating activities in a balanced manner between investment and shareholder returns.

Quality of Earnings

Profit at the Ordinary Income level was supported by growth in Operating Income and non-operating income, including dividend income of ¥12.4B and foreign exchange gains of ¥6.7B, indicating an improvement in the recurring earnings structure. Meanwhile, extraordinary losses of ¥14.7B, including ¥9.9B in losses on disposal of fixed assets and ¥1.1B in impairment losses on investment securities, reduced Profit Before Tax to ¥79.5B as a temporary factor. However, income taxes and other taxes resulted in a tax benefit of ¥54.8B, lifting Net Income to ¥134.3B and creating a significant gap between Profit Before Tax and Net Income. This tax benefit is strongly one-off in nature, and given the possibility of reversal or contraction from the Full Year onward, it is not appropriate to regard the high Net Income growth rate as representing normalized earnings power. The fact that OCF was generated at a level exceeding Net Income provides support for the quality of earnings.

Earnings Forecast and Guidance

Progress against the Company’s Full-Year forecast was 74.3% for Revenue and 75.6% for Operating Income, broadly within standard levels. Ordinary Income had reached 85.4% and Net Income 91.5% of the respective forecasts, indicating that lower-line profit, which includes non-operating income and tax effects, is more likely to exceed plan. The Full-Year forecast calls for Revenue of ¥1,300.0B (-8.6% YoY), Operating Income of ¥100.0B (+18.5%), and Ordinary Income of ¥110.0B (+13.8%), implying a Full-Year Operating Margin of approximately 7.7%. The cumulative Q3 Operating Margin of 7.8% is slightly above the planned level, making the Company’s ability to maintain profitability improvements from the second half onward the key focus.

Shareholder Returns

The Q2 dividend was ¥85.00 per share, while the Full-Year forecast dividend is ¥170.00 per share. The forecast Payout Ratio against forecast EPS of ¥632.86 is approximately 26.9%, a sustainable level. The highly net-cash-oriented financial structure, with cash and deposits of ¥310.2B and minimal interest-bearing debt, supports continued dividend payments. Cumulative Q3 Free Cash Flow of ¥104.2B significantly exceeded dividend payments of ¥37.5B, and no significant cash outflow from share repurchases has been identified.

Risk Factors

1. Deterioration in profitability of the Lifestyle and Health Industry-Related segment: Revenue in this segment declined 50.0% YoY to ¥129.8B, and the segment fell into an Operating Loss of ¥1.4B. Demand recovery and progress in business reorganization remain constraints on company-wide growth.

2. Extension of the trade receivables collection period: Accounts receivable and notes receivable increased to ¥375.9B, while the increase in trade receivables was also a negative factor of ¥20.99B in OCF. Trends in collection efficiency could affect future working capital requirements.

3. Considerations regarding the quality of Net Income: The significant increase in Net Income for the current period was supported by a tax benefit of ¥54.8B from income taxes and other taxes. If the tax effect reverses or contracts, Net Income and ROE may fluctuate.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The Operating Margin is slightly below the industry median, while the Net Income Margin is significantly above the industry median, partly due to the impact of the tax benefit.

Growth and Capital Efficiency

The Revenue Growth Rate is significantly below the industry median, with the Company’s revenue decline standing out even within the industry.

※Source: Compiled by the Company

Key Points from the Earnings Results

1. Even amid lower revenue, the Operating Margin improved to 7.8%, clearly demonstrating a structure in which the highly profitable Petroleum and Transportation Equipment and Information, Electrical and Electronic businesses are driving company-wide profit.

2. OCF generated Free Cash Flow of ¥104.2B, providing strong cash backing for earnings. However, it should be noted that the significant impact of the tax benefit is included in the increase in Net Income.

3. The Lifestyle and Health Industry-Related segment’s shift into the red and the increase in trade receivables remain points requiring ongoing monitoring when assessing the future earnings structure and capital efficiency.

Theoretical Share Price (Reference Value)

Sensitivity: ¥6,759–¥7,157 at Cost of Equity ±1%; ¥6,952–¥6,956 at ω±0.1.

Notes:

• Because progress toward forecast Net Income (91%) exceeds the standard level (75%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies ahead of plan tend to exceed forecasts; adjustments may be excessive for businesses with strong seasonality).
• Net assets at the end of the quarter are used (there is a timing difference relative to the Full-Year forecast).

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional advisor as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 performance was operationally resilient despite a sharp contraction in sales, while bottom-line profit was amplified by a substantial tax benefit. Revenue declined 13.1% YoY to ¥96.6bn. Operating income nevertheless increased 10.0% YoY to ¥7.56bn. The operating margin expanded to 7.8% from 6.2% a year earlier, an improvement of approximately 163bp. Gross profit was essentially flat at ¥24.93bn despite the revenue decline, lifting the gross margin to 25.8% from 22.4%, or approximately 340bp. This indicates that pricing, product mix, and/or lower input costs more than offset the reduced sales base. SG&A expense declined 3.5% YoY to ¥17.37bn, although it rose as a percentage of revenue because sales declined faster than overhead. Ordinary income rose 9.4% to ¥9.39bn, supported by ¥2.15bn of non-operating income, including ¥1.24bn of dividend income and ¥0.67bn of foreign-exchange gains. Profit attributable to owners of parent surged 251.8% YoY to ¥12.81bn. The main driver of this divergence from operating and ordinary profit growth was a ¥5.48bn income-tax benefit, producing a negative effective tax rate of 68.9%. Consequently, the 13.3% reported net margin and 11.0% annualized ROE materially overstate the underlying recurring operating earnings power. Cash earnings were strong: operating cash flow was ¥15.06bn, equivalent to 1.18x profit attributable to owners, and free cash flow was ¥10.42bn. The balance sheet remains exceptionally conservative, with ¥31.02bn in cash against only ¥2.65bn of interest-bearing debt. The company has already achieved 74.3% of full-year revenue guidance and 75.6% of operating-income guidance after nine months, broadly in line with the standard 75% Q3 progress benchmark. Profit attributable to owners has reached 91.5% of the full-year forecast, but this is principally due to the tax benefit and should not be extrapolated mechanically. The principal operational issue is the Life & Health-related business, where sales nearly halved and the segment recorded a loss. A further issue requiring active monitoring is annualized receivable days of 107 days, well above the 60-day warning threshold. Overall, the quarter demonstrates improved core margin discipline and very strong cash generation, but the sustainability of reported net profit depends on the recurrence of the tax benefit and on stabilization of weak businesses.

Profitability Analysis

The reported annualized DuPont ROE is 11.0%, comprising a 13.3% net profit margin, 0.667x annualized asset turnover, and 1.24x financial leverage. The largest contributor to the elevated ROE is the net margin rather than leverage, as the capital structure remains lightly indebted and financial leverage is modest. The net margin is distorted upward by the ¥5.48bn income-tax benefit; profit before tax was ¥7.95bn, below ordinary income of ¥9.39bn due principally to extraordinary losses of ¥1.47bn, including ¥0.99bn of fixed-asset disposal losses. The tax burden ratio of 1.611x confirms that net income exceeded pre-tax income, an unusual outcome that should be treated as non-recurring until proven otherwise. The interest burden of 1.052x reflects net non-operating income and very limited financing costs, rather than financial strain. Operating profitability improved meaningfully: the gross margin increased approximately 340bp YoY to 25.8%, while the operating margin rose approximately 163bp to 7.8%. EBITDA was ¥14.44bn and the EBITDA margin was 14.9%, indicating solid cash profitability before depreciation and amortization. SG&A decreased to ¥17.37bn from ¥18.00bn, but SG&A intensity rose to 18.0% of sales from 16.2%; continued revenue contraction would therefore constrain further operating leverage. The Petroleum & Transportation-related segment is the core business by operating-income contribution, generating ¥4.38bn of segment profit on ¥36.91bn of sales, for an 11.9% margin, up from 8.2% a year earlier. The Information & Electronics-related segment was the highest-margin major profitable segment, delivering ¥2.62bn of profit on ¥17.11bn of sales, or a 15.3% margin, versus 13.1% a year earlier. Plastics & Textile-related sales declined 3.9% to ¥19.64bn and segment profit fell 21.8% to ¥1.76bn, compressing its margin to 9.0% from 11.0%. Petroleum & Transportation-related sales declined only 1.7%, while segment profit increased 41.5%, evidencing substantial margin recovery. Information & Electronics-related sales increased 7.7% and segment profit increased 25.7%, making it the clearest growth-and-margin contributor. Life & Health-related sales fell 50.0% to ¥12.98bn and the segment moved to a ¥0.14bn loss from a ¥0.21bn profit. Environment & Housing-related sales declined 11.9% to ¥9.97bn and its loss widened modestly to ¥0.04bn. Unallocated corporate expenses, mainly R&D for new businesses, increased to ¥1.02bn from ¥0.81bn; this is strategically important spending but offsets part of the segment-level profit improvement.

Growth Assessment

Revenue contraction remains the central growth challenge, with nine-month sales down ¥14.51bn YoY. The decline was concentrated in Life & Health-related products, where revenue decreased ¥12.96bn YoY, accounting for most of the consolidated sales reduction. Excluding this business, the remaining portfolio was comparatively stable, with Petroleum & Transportation-related sales down modestly, Plastics & Textile-related sales slightly lower, Information & Electronics-related sales higher, and Environment & Housing-related sales lower. Information & Electronics is the most constructive segment trend because it combined 7.7% sales growth with a 220bp margin expansion. Petroleum & Transportation also showed strong earnings resilience, with profit growth despite lower revenue. The decline in finished goods inventory to ¥12.41bn from ¥12.97bn is consistent with inventory discipline in a lower-sales environment. Raw-material inventory increased 4.9% to ¥4.70bn, which leaves some exposure to chemical feedstock and commodity-cost movements. Full-year guidance calls for revenue of ¥130.0bn, down 8.6% YoY, operating income of ¥10.0bn, up 18.5%, and ordinary income of ¥11.0bn, up 13.8%. Nine-month revenue progress is 74.3%, 0.7 percentage points below the standard 75% Q3 pace, while operating-income progress is 75.6%, 0.6 percentage points above it. This implies that the company must preserve the improved margin profile in Q4 to achieve guidance, even if sales remain soft. Profit attributable to owners progress of 91.5% versus the ¥14.0bn full-year forecast is substantially ahead of a normal 75% pace, but it primarily reflects the tax benefit rather than a comparable acceleration in recurring operations. Capital expenditure was ¥4.88bn, equal to 5.1% of nine-month sales, a normal manufacturing investment level. Capex represented 0.71x depreciation and amortization, indicating spending below depreciation and more consistent with maintenance or selective investment than broad capacity expansion.

Financial Health

Liquidity is very strong. Current assets of ¥94.01bn exceed current liabilities of ¥33.78bn, resulting in a 278.3% current ratio and a 241.6% quick ratio. Working capital totals ¥60.23bn, providing a substantial buffer against short-term obligations. Cash and deposits increased 26.4% YoY to ¥31.02bn and represent 16.1% of total assets. Interest-bearing debt is only ¥2.65bn, comprising ¥0.42bn of short-term loans and ¥2.23bn of long-term loans. The short-term debt ratio is 15.9%, and cash covers short-term debt by 73.68x, so there is no material maturity-mismatch risk. Debt/EBITDA is just 0.18x, debt/capital is 1.7%, and EBITDA interest coverage is 169.89x. The reported debt-to-equity ratio of 0.24x is well below the 2.0x warning threshold. Total liabilities account for only 19.5% of total assets, while total equity is ¥155.48bn and the capital adequacy ratio is 78.9%. Investment securities increased 28.7% YoY to ¥39.53bn and now account for 20.5% of total assets. This sizeable securities portfolio enhances balance-sheet flexibility, but it also makes comprehensive income and net asset value sensitive to equity-market valuation changes. Indeed, valuation differences on securities increased to ¥18.04bn, helping lift total comprehensive income to ¥21.30bn. Property, plant and equipment is ¥44.90bn, or 23.2% of total assets, indicating a moderate manufacturing fixed-asset base rather than excessive capital intensity. Intangible assets are limited at 2.8% of assets, reducing acquisition-related amortization and impairment dependency. There are no disclosed balance-sheet indicators of solvency stress.

Notable B/S Changes

Investment securities: +¥8.82bn (+28.7%) to ¥39.53bn — now 20.5% of total assets; increases financial flexibility but raises OCI and equity sensitivity to market valuation movements. Cash and deposits: +¥6.49bn (+26.4%) to ¥31.02bn — reflects strong net cash generation and reinforces already substantial liquidity. Total equity: +¥17.18bn (+12.4%) to ¥155.48bn — supported by retained earnings and positive accumulated other comprehensive income, strengthening the capital base. Accounts receivable: +¥2.53bn (+7.2%) to ¥37.59bn — growth in receivables alongside the 107-day annualized DSO warrants monitoring of collection efficiency and customer credit exposure. Electronically recorded obligations: +¥2.02bn (+69.3%) to ¥4.93bn — contributed to the increase in trade payables and supported operating cash flow, but payment-term dynamics should be monitored.

Cash Flow Quality

Cash-flow quality is high based on the available nine-month data. Operating cash flow was ¥15.06bn, exceeding ¥12.81bn of profit attributable to owners by 1.18x. The OCF/net-income ratio is above the 1.0x high-quality threshold and does not indicate an earnings-cash conversion concern. Cash conversion, measured as OCF/EBITDA, was 1.04x, also evidencing strong conversion of operating earnings into cash. The accruals ratio was negative 1.2%, which is favorable and suggests that cash realization was stronger than accounting accrual income. Free cash flow was ¥10.42bn after investing cash outflow of ¥4.64bn, providing ample internally generated funds. Capital expenditure cash outflow was ¥4.88bn, lower than ¥5.34bn in the prior year and below depreciation of ¥6.88bn. Working-capital cash flow was favorable overall: trade payables increased by ¥3.76bn and inventories decreased by ¥0.48bn, while trade receivables increased by ¥2.10bn. The receivable increase partially offsets the otherwise favorable working-capital performance. The quality alert for annualized DSO of 107 days is material: it is substantially above the 60-day warning level and means a large amount of cash remains tied up in customer balances. This can reflect customer mix, contractual billing terms, or slower collection, but its persistence would elevate credit risk and constrain cash conversion. Accounts receivable were ¥37.59bn, equal to 19.5% of total assets, making collections a key operating metric. The current cash-flow outcome remains robust, but improvement in payable timing should not be viewed as a substitute for reducing the extended collection cycle. Financing cash outflow of ¥4.54bn mainly reflects ¥3.75bn of cash dividends and debt repayment, while cash increased by ¥6.49bn over the period.

Dividend Sustainability

Dividend sustainability appears strong on current cash-flow and balance-sheet metrics. The interim dividend was ¥85 per share, and the full-year forecast dividend is ¥170 per share. Against forecast EPS of ¥632.86, the implied full-year dividend payout ratio is approximately 26.9%, comfortably below the 60% sustainability benchmark. The calculated interim payout ratio of 15.6% is low because it captures only the ¥85 interim distribution relative to nine-month earnings. Free cash flow of ¥10.42bn covers the interim dividend requirement by 5.21x. Cash and deposits of ¥31.02bn, negligible debt, and interest coverage of 169.89x provide considerable financial capacity to maintain the stated dividend. Cash dividends paid during the nine months were ¥3.75bn, broadly consistent with the prior year. No meaningful share repurchase activity is indicated by the ¥0.02bn treasury-stock cash outflow, so the dividend payout ratio remains the appropriate shareholder-return measure. The main qualification is that nine-month net income was boosted by a large tax benefit; dividend capacity should therefore be assessed primarily against recurring operating cash flow and normalized earnings. On that basis, the current ¥170 per-share forecast remains well supported by ¥15.06bn of operating cash flow and ¥10.42bn of free cash flow.

Risk Assessment

Business risks include High priority — Life & Health-related business deterioration: segment sales fell 50.0% YoY to ¥12.98bn and the segment recorded a ¥0.14bn loss, versus a ¥0.21bn profit previously. Recovery timing and the adequacy of restructuring actions are central risks., High priority — Customer-collection risk: annualized DSO is 107 days, above the 60-day quality-alert threshold. The extended cash-conversion cycle increases exposure to counterparty credit conditions and could weaken operating cash flow if receivables continue to rise., Medium priority — Chemical-manufacturing input-cost and demand cyclicality: margins improved sharply this period, but raw-material prices, energy costs, industrial production levels, and customer inventory adjustments can reverse pricing and mix benefits., Medium priority — Portfolio concentration in cyclical industrial end markets: Petroleum & Transportation-related products are the largest profit contributor and may be exposed to automotive production, fuel-transition dynamics, and global industrial demand., Medium priority — Information & Electronics execution risk: this is the strongest growth segment, but demand may be sensitive to electronics-cycle volatility and customer qualification cycles..

Financial risks include Low priority — Tax-benefit reversal: the ¥5.48bn income-tax benefit drove the negative 68.9% effective tax rate and elevated reported net income. Future tax rates reverting toward normal levels would reduce net profit and ROE even if operating profit holds., Low-to-medium priority — Investment-security valuation sensitivity: investment securities of ¥39.53bn equal 20.5% of assets, and the securities valuation reserve is significant. Market-price movements can cause material OCI and equity volatility., Low priority — Fixed-asset disposal and restructuring costs: extraordinary losses were ¥1.47bn, including ¥0.99bn of disposal losses. While lower than the prior year's ¥2.37bn extraordinary losses, further portfolio actions could produce additional charges..

Key concerns include The quality alert on 107-day DSO must be addressed. The root cause is a very large receivables balance relative to annualized sales; regardless of whether it reflects contractual terms or collection speed, it lengthens the cash cycle. In a chemicals and industrial-materials context, collection periods can vary by customer and channel, but 107 days is above the stated warning level. The impact is heightened working-capital and customer-credit risk, although current operating cash flow remains strong., Reported net income is not fully representative of recurring profitability because net income exceeded profit before tax as a result of the tax benefit. Investment analysis should emphasize operating income, ordinary income, EBITDA, and cash flow rather than the headline net-profit growth rate., Sales remain below the prior-year level, and the improved consolidated margin currently relies heavily on Petroleum & Transportation and Information & Electronics performance offsetting severe weakness in Life & Health..

Investment Implications

Key takeaways include Core operating earnings improved: operating income rose 10.0% YoY despite a 13.1% revenue decline, and the operating margin increased approximately 163bp to 7.8%., The Petroleum & Transportation-related segment is the principal profit engine, while Information & Electronics provides the strongest combination of revenue growth and margin expansion., Net-income growth of 251.8% YoY is materially tax-benefit driven and should not be treated as a direct measure of recurring earnings momentum., Cash generation is strong, with ¥15.06bn of operating cash flow, ¥10.42bn of free cash flow, 1.18x OCF/profit attributable to owners, and 1.04x OCF/EBITDA., The capital structure is highly conservative, with ¥31.02bn of cash, ¥2.65bn of interest-bearing debt, 0.18x debt/EBITDA, and a 78.9% capital adequacy ratio., The 107-day annualized receivable cycle and the loss-making Life & Health-related business are the most important counterweights to the otherwise improved operating and cash-flow profile..

Metrics to watch include Life & Health-related segment sales, segment margin, and restructuring outcomes, Annualized DSO and absolute accounts-receivable balance, Operating-margin retention as Q4 revenue approaches the ¥130.0bn full-year sales target, Information & Electronics-related segment growth and margin, Petroleum & Transportation-related segment margin resilience against raw-material, energy, and automotive-cycle changes, Normalized effective tax rate and the recurrence of tax-related gains or losses, Investment-securities valuation movements and their impact on OCI and equity, Capex relative to depreciation, currently 0.71x.

Regarding relative positioning, Relative to typical manufacturing credit benchmarks, the company is positioned very conservatively: liquidity, debt service capacity, and free-cash-flow generation are strong. Profitability has improved to a mid-single-digit-to-good operating-margin range, although it remains below the 8% threshold commonly viewed as a strong operating-margin level. The primary relative weakness is working-capital efficiency, specifically the 107-day receivables cycle, alongside uneven portfolio performance caused by the Life & Health-related segment contraction.